BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang YQ, Guo JS. Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2015; 21(13): 3860-3866 [PMID: 25852270 DOI: 10.3748/wjg.v21.i13.3860]
URL: https://www.wjgnet.com/1007-9327/full/v21/i13/3860.htm
Number Citing Articles
1
Zhikai Zheng, Jiongliang Wang, Tianqing Wu, Minrui He, Juncheng Wang, Yangxun Pan, Jinbin Chen, Dandan Hu, Li Xu, Yaojun Zhang, Minshan Chen, Zhongguo Zhou. Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion ChemotherapyJournal of Hepatocellular Carcinoma 2023; : 2117 doi: 10.2147/JHC.S436062
2
Liuqing Yang, Qiang Wang, Tingting Cui, Jinxin Huang, Hui Jin, Stefano Gitto. Reporting and Performance of Hepatocellular Carcinoma Risk Prediction Models: Based on TRIPOD Statement and Meta-AnalysisCanadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/9996358
3
Liting You, Juan Zhou, Zhaodan Xin, J Spencer Hauck, Feifei Na, Jie Tang, Xiaohan Zhou, Zichen Lei, Binwu Ying. Novel directions of precision oncology: circulating microbial DNA emerging in cancer-microbiome areasPrecision Clinical Medicine 2022; 5(1) doi: 10.1093/pcmedi/pbac005
4
C. Graf, G. Dultz. Therapie der Hepatitis C: Welche Problemkonstellationen gibt es noch?Der Gastroenterologe 2021; 16(6): 442 doi: 10.1007/s11377-021-00566-8
5
Stefan Zeuzem. Treatment Options in Hepatitis CDeutsches Ärzteblatt international 2017;  doi: 10.3238/arztebl.2017.0011
6
Kyungtaek Im, Jisu Kim, Hyeyoung Min. Ginseng, the natural effectual antiviral: Protective effects of Korean Red Ginseng against viral infectionJournal of Ginseng Research 2016; 40(4): 309 doi: 10.1016/j.jgr.2015.09.002
7
Ragunath Barath, Kaviarasan Vaishak, Ramakrishnan Veerabathiran. Oncogenic Viruses2023; : 145 doi: 10.1016/B978-0-12-824152-3.00011-1
8
Hanan Omar, Samaa Taha, Wafaa Hassan, Hamdy Omar. Occult hepatitis B infection: a hidden factor of poor response to intervention treatment of hepatocellular carcinoma in chronic hepatitis C patientsComparative Clinical Pathology 2018; 27(5): 1273 doi: 10.1007/s00580-018-2735-0
9
Yuanling Niu, Hao Kang, Pingyang Wang, Chenchen Guo, Fan Nie, Hongbin Ji, Jiarui Wu, Luonan Chen. Why Increase of Heterogeneity Signals Pre-Deterioration During Tumor Progression: A Unified Mathematical ModelSIAM Journal on Applied Mathematics 2023; 83(2): 791 doi: 10.1137/22M1497729
10
Angela Chau, Ming-Lun Yeh, Pei-Chien Tsai, Daniel Q. Huang, Sung Eun Kim, Huy Trinh, Eileen L. Yoon, Hyunwoo Oh, Jae Yoon Jeong, Sang Bong Ahn, Jihyun An, Cheng-Hao Tseng, Yao-Chun Hsu, Soung Won Jeong, Yong Kyun Cho, Jae-Jun Shim, Hyoung Su Kim, Takanori Ito, Sebastián Marciano, Keigo Kawashima, Takanori Suzuki, Tsunamasa Watanabe, Akito Nozaki, Toru Ishikawa, Kaori Inoue, Yuichiro Eguchi, Haruki Uojima, Hiroshi Abe, Hirokazu Takahashi, Makoto Chuma, Masatoshi Ishigami, Joseph K. Hoang, Mayumi Maeda, Chung-Feng Huang, Adrian Gadano, Chia-Yen Dai, Jee-Fu Huang, Yasuhito Tanaka, Wan-Long Chuang, Seng Gee Lim, Ramsey Cheung, Ming-Lung Yu, Dae-Won Jun, Mindie H. Nguyen. Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal StudyClinical Gastroenterology and Hepatology 2024; 22(3): 572 doi: 10.1016/j.cgh.2023.09.002
11
Yen-Hao Chen, Chih-Chi Wang, Yen-Yang Chen, Jing-Houng Wang, Chao-Hung Hung, Yuan-Hung Kuo. Low-dose nivolumab in advanced hepatocellular carcinomaBMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10271-6
12
Uyen Mui, Christopher Haley, Stephen Tyring. Viral Oncology: Molecular Biology and PathogenesisJournal of Clinical Medicine 2017; 6(12): 111 doi: 10.3390/jcm6120111
13
Amy Lee, Fa-Chyi Lee. Medical oncology management of advanced hepatocellular carcinoma 2019: a reality checkFrontiers of Medicine 2020; 14(3): 273 doi: 10.1007/s11684-019-0728-2
14
Sahith Kudaravalli, Leslie Y. Kam, Daniel Q. Huang, Ramsey Cheung, Mindie H. Nguyen. Utilization of Antiviral Therapy for Patients With Hepatitis B–Related Hepatocellular Carcinoma: A Nationwide Real-World US StudyClinical Gastroenterology and Hepatology 2023; 21(13): 3305 doi: 10.1016/j.cgh.2023.04.020
15
Derek J. Erstad, Allen A. Razavi, Shen Li, Kenneth K. Tanabe, Bryan C. Fuchs. Hepatocellular CarcinomaMolecular and Translational Medicine 2019; : 255 doi: 10.1007/978-3-030-21540-8_13
16
Hou-Ying Cheng, Cheng-Maw Ho, Chih-Yang Hsiao, Ming-Chih Ho, Yao-Ming Wu, Po-Huang Lee, Rey-Heng Hu. Interval dynamics of transplantability for hepatocellular carcinoma after primary curative resection: risk factors for nontransplantable recurrenceHPB 2023; 25(2): 218 doi: 10.1016/j.hpb.2022.10.010
17
春晓 朱. Comparison of the Clinical Curative Efficacy of Interferon Monotherapy and Combined with Nucleotide Analogues in the Treatment-Naive Patients with Chronic Hepatitis BAdvances in Clinical Medicine 2024; 14(06): 319 doi: 10.12677/acm.2024.1461779